Maintenance therapy prolongs survival in lymphoma, leukemia, myeloma, sarcoma, ovarian and other types of cancer.
Tecentriq® Improves NSCLC survival when combined with Avastin & chemotherapy Regardless of PD-L1 Status.
TOURMALINE-MM3 clinical trials demonstrates Ninlaro can be used as maintenance therapy for multiple myeloma.
ASH Highlights Blincyto, REGN1979 and AMG420 BiTE® antibody immunotherapy for lymphomas and myeloma.
Fatigue and Cancer go hand in hand - learn what you can do to help overcome being tired.
Learn who's at risk and how breast cancer is diagnosed and prevented
Breast cancer surgeon Dr. Kirstein of MSKCC is taking questions about the management of high risk breast caner this week
Update on Rx of Hot Flashes from San Antonio Meetings. Oxybutinim, Anit-depressants, Acupuncture and more.
Cancer Connect - Treatment of In Situ & Stage 1 Melanoma
DCVAax trial update provided-still looks promising:
HER 2 + Lung Cancer Treatment?
"some evidence" that cell phones cause brain tumors in rats;
Is Adavosertib ready for sarcoma clinical trials?
Interesting data published this week show HDC appears to benefit TNBC:
New Antibody that targets CD74 on myeloma cells gets nod from FDA to proceed.
Long-Term Follow-Up Indicates Continued Improvement in Survival with Addition of Rituxan® to CHOP in NHL
Can very high dose radiation cure metastatic cancer?
Should the blood biopsy replace the tissue biopsy?